Pharmafile Logo
Pharmafocus logo
Advanced Search

Purdue-owning Sackler family own second opioid drug maker, FT reveals

September 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing OxyContin, Purdue Pharma, opioid, opioid crisis, sackler

The billionaire Sackler family, the owners of OxyContin drugmaker Purdue Pharma, have been revealed to own a second opioid drug …

News

Novo Nordisk stockpiles 16 weeks’ worth of insulin in preparation for hard Brexit

September 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Novo Nordisk, UK, brexit, insulin, pharma, stockpiles

Danish multinational Novo Nordisk has announced that they are increasing their stocks of insulin products to ensure that there are …

News
drug_safety

Drug safety: UK and EU post-Brexit

September 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Europe, MHRA, UK, brexit, drug safety, pharmacovigilance

What does Brexit mean for drug safety in Europe and the United Kingdom? Louis Goss looks into Britain’s exit from …

Feature
opdivo_1_1

BMS’ Opdivo fails to win over NICE as adjuvant melanoma therapy

September 10, 2018
Sales and Marketing BMS, NHS, NICE, melanoma, opdivo, pharma

Bristol-Myers Squibb has failed to convince NICE to approve the use of its PD-1 inhibitor immunotherapy Opdivo (nivolumab) as an …

News
merckentranceweb

Keytruda scores ground-breaking European approval in lung cancer subgroup

September 10, 2018
Sales and Marketing Cancer, EU, Europe, MSD, Merck, NSCLC, keytruda, lung cancer, pharma

Keytruda (pembrolizumab) has chalked up yet another approval for MSD, this time in Europe in combination with permextred and platinum-based …

News

GSK’s Nucala data insufficient for US COPD approval

September 10, 2018
Sales and Marketing COPD, FDA, GSK, Nucala, US, pharma

GlaxoSmithKline has suffered a regulatory blow in the label expansion of its interleukin-5 (IL5) inhibitor Nucala (mepolizumab), with the FDA …

News

Akcea cuts 10% of staff following FDA rejection

September 10, 2018
Manufacturing and Production, Sales and Marketing Akcea, FDA, Waylivra, pharma

Akcea Therapeutics has been hit hard by the FDA’s decision to reject its drug Waylivra (volanesorsen) for the treatment of …

News

NICE rejects Roche’s Ocrevus in primary progressive multiple sclerosis

September 10, 2018
Sales and Marketing NICE, Ocrevus, Roche, UK, multiple sclerosis, pharma

Of the 100,000 MS patients in England, around one in eight have the primary progressive form (PPMS), which brings debilitating …

News
nhs_sign

UK Government to invest £200m in IT and technology boost for NHS

September 7, 2018
Medical Communications, Sales and Marketing AI, Matt Hancock, NHS, NHS expo, pharma

The UK Government has lifted the curtain on plans invest more than £200 million to leverage innovations in technology and …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

September 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, MHRA, Trump, brexit, research, scandal, top 10

Brexit took the top two spots this week after it was revealed that the EMA has awarded Britain’s MHRA just …

News
canadian-flag-1229484_960_720

BC Liberal criticises opioid lawsuit for focusing too heavily on drugmakers

September 7, 2018
Medical Communications

The British Columbia Liberal opposition Critic for Mental Health and Addictions has tweeted that the lawsuits seeking damages from pharmaceutical …

News
gilead-sciences

Gilead and Galapagos’ ankylosing spondylitis drug hits Phase 2 trial goal

September 7, 2018
Medical Communications, Research and Development Galapagos, Gilead, ankylosing spondylitis, filgotinib, pharma

Gilead and Galapagos have announced that their jointly-developed selective JAK1 inhibitor filgotinib has met its primary endpoint in a Phase …

News
5204602349_c87b204860_z

FDA recruitment official says Trump’s policies are making hiring difficult

September 7, 2018
Medical Communications FDA, Trump, US, hiring, recruitment

Melanie Keller, Acting Associate Commissioner for Scientific and Clinical Recruitment at the US Food and Drug Administration (FDA) has said …

News
sanjay_keswani

Rheos Medicines appoints Roche Senior Vice President and R&D head as new CEO

September 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, CEO, Roche, cembridge, massachussets, rheos, sanjay keswani

The Cambridge Massachusetts-based biopharmaceutical company Rheos Medicines has appointed former Roche Senior Vice President and Global R&D Head, Dr Sanjay …

Appointment
pshezhetskiy

A rational new approach to cancer treatment

September 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, University of East Anglia, feature, pharma

Researchers at the University of East Anglia have developed a new targeted cancer therapy which utilises nanoparticles to deliver treatment …

Feature

Novartis sells key Sandoz US portfolios to Aurobindo for $1bn

September 6, 2018
Sales and Marketing Aurobindo, Novartis, Sandoz, pharma

Novartis has revealed it is to sell the dermatology and generic US oral solids portfolios of its generics arm Sandoz …

News
teva_canada_1

Teva drops MS and Huntington’s disease drug laquinimod, leaving rights to Active Biotech

September 6, 2018
Medical Communications, Research and Development Active Biotech, Laquinimod, Teva, pharma

Israeli multinational Teva Pharmaceutical has decided to discontinue the development of laquinimod. As such, all rights for the orally administered …

News
shibam_wadi_hadhramaut_yemen

WHO ship 500 tons of medicine to Yemen

September 6, 2018
Manufacturing and Production Sanaa, WHO, Yemen, middle east, sana'a, war

The World Health Organisation (WHO) has airlifted more than 500 tons of medicines to Yemen over the previous month in …

News
gsk_boronia_australia

GSK to axe 650 positions across US workforce

September 6, 2018
Manufacturing and Production GSK, GlaxoSmithKline, pharma

GlaxoSmithKline has announced its intention to cut 650 employees from its current US workforce, with the cutbacks coming as part …

News
24327909026_6435de0904_z

Ketamine’s antidepressant effects may be linked to brain’s opioid system

September 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ketamine, antidepressant, depression, mental health, opioid

Ketamine’s antidepressant effect works through the activation of the brains opioid receptors, a new study published in The American Journal …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026